Figure 1From: Atorvastatin for preventing the progression of sepsis to severe sepsis (ASEPSIS Trial): a randomised, double-blind, placebo-controlled trial (ISRCTN64637517)Percentage of patients progressing to severe sepsis (%).Back to article page